Natco enters agreement to acquire Dash PharmaceuticalsThe acquisition of Dash Pharmaceuticals will provide additional opportunities in the United States, the company said. Advanz Pharma welcomes new executivesAdvanz Pharma named Steffen Wagner as its CEO and appointed Andreas Stickler as its chief financial officer. BioTek reMEDys to provide Uplizna Uplizna is used to treat adults with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive. Endo to supply Vasostrict through Premier Vasostrict is used in critical care, including some of the most acute cases of COVID-19. Sun Pharma debuts Winlevi Winlevi provides a topical treatment for acne vulgaris in patients aged 12 years old and older. Publix Pharmacy named recipient of patient choice award Publix Pharmacy received the Retail Specialty Pharmacy Patient Choice Award by Zitter Insights. The Vistria Group acquires BioCare The Vistria Group has acquired BioCare, a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy and logistics services. Azurity Pharmaceuticals gets FDA OK for Eprontia Eprontia provides a ready-to-use liquid medication for patients who have trouble swallowing pills. Tris Pharma acquires FDA OK for Dyanavel Dyanavel XR offers treatment for patients age 6 years old and older with ADHD. ANI closes $75M public offering of common stock A total of 1,500,000 shares of ANI's common stock were sold at a public offering price of $50 per share. First Previous 10 11 12 13 14 Next Last
